Balghith Mohammed Ali, Almutairi Ahmed Ammar, Almohini Ibrahim Abdulelah, Albadah Abdullah Rasheed, Almutairi Ahmed Ayed, Alhamdan Abdulrahman Abdulaziz, Alshareef Hamza Shakir, Alkheraiji Meshal Abdullah
King Abdulaziz Cardiac Center, College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Heart Views. 2020 Oct-Dec;21(4):245-250. doi: 10.4103/HEARTVIEWS.HEARTVIEWS_28_20. Epub 2021 Jan 14.
Diabetes mellitus is a metabolic disorder that causes impaired insulin secretion or cellular dysfunction. Glycated hemoglobin (HbA1c) indicates the long-term level of glucose. Diabetes can lead to cardiovascular complications such as acute coronary syndrome , which might require coronary intervention.
The aim of this study was to estimate the effect of glycemic control measured by HbA1c levels on cardiac complications in Saudi diabetic patients who underwent percutaneous coronary intervention (PCI) or Coronary artery bypass graft (CABG).
It was a cohort retrospective study conducted at King Abdulaziz Cardiac Center with a total sample size of 379 patients. The charts of all those diabetic patients were reviewed and their HbA1c level, type of intervention were compared to determine their effect on cardiac outcomes and complications. Inclusion criteria involved the age group 50-70 years within follow-up period of 3 years. Any patient known to have renal failure, liver dysfunction, type one diabetes, and cancer were excluded. The HbA1c level was divided into two groups (<7.5%, ≥7.5%).
Total sample size was 379, and the mean age was (60.33 ± 5.98) with male being (66.5%). HbA1c levels at admission were (mean 9.15 ± 2.03), whereas the mean after 3 years was (8.629 ± 1.518). The uncontrolled group was more likely to have PCI ( = 302), in comparison to the controlled group ( = 77) with a value of 0.04. However, the controlled group was more likely to undergo medical treatment value of 0.001. Patients with uncontrolled Hba1c after the intervention had a higher readmission rate with a value of 0.018.
Patients with an elevated level of HbA1c were more likely to be managed with PCI. Furthermore, they are at a higher risk of multiple readmissions. Patients who had CABG were at a lower risk of cardiac complications. Further studies are required in our population to consider different approaches of diabetes control for preventing adverse outcomes.
糖尿病是一种导致胰岛素分泌受损或细胞功能障碍的代谢紊乱疾病。糖化血红蛋白(HbA1c)可反映长期血糖水平。糖尿病可导致心血管并发症,如急性冠状动脉综合征,可能需要进行冠状动脉介入治疗。
本研究旨在评估通过HbA1c水平衡量的血糖控制对接受经皮冠状动脉介入治疗(PCI)或冠状动脉旁路移植术(CABG)的沙特糖尿病患者心脏并发症的影响。
这是一项在阿卜杜勒阿齐兹国王心脏中心进行的队列回顾性研究,总样本量为379例患者。回顾了所有这些糖尿病患者的病历,比较了他们的HbA1c水平、干预类型,以确定其对心脏结局和并发症的影响。纳入标准包括年龄在50 - 70岁之间、随访期为3年。已知患有肾衰竭、肝功能不全、1型糖尿病和癌症的任何患者均被排除。HbA1c水平分为两组(<7.5%,≥7.5%)。
总样本量为379例,平均年龄为(60.33 ± 5.98)岁,男性占(66.5%)。入院时HbA1c水平为(平均9.15 ± 2.03),而3年后平均水平为(8.629 ± 1.518)。与对照组(n = 77)相比,未控制组更有可能接受PCI(n = 302),P值为0.04。然而,对照组更有可能接受药物治疗,P值为0.001。干预后HbA1c未控制的患者再入院率更高,P值为0.018。
HbA1c水平升高的患者更有可能接受PCI治疗。此外,他们多次再入院的风险更高。接受CABG的患者心脏并发症风险较低。需要在我们的人群中进行进一步研究,以考虑不同的糖尿病控制方法来预防不良结局。